Abstract
IN multinucleated heterokaryons formed from the fusion of differentiated muscle cells to either hepatocytes or fibroblasts, muscle-specific gene expression is activated, liver-specific gene expression is repressed, and there are changes in the location of the Golgi apparatus1–3. An understanding of the regulatory mechanisms that underlie this plasticity is of particular interest given the stability of the differentiated state in vivo. We have now investigated whether MyoD or myogenin, regulators of muscle-specific gene expression that have a helix–loop–helix motif4–7, can induce the phenotypic conversion observed in heterokaryons. When these regulators were stably or transiently introduced into fibro-blasts or hepatocytes by microinjection, transfection or retroviral infection with complementary DNA in expression vectors, fibro-blasts expressed muscle-specific genes, whereas hepatocytes did not. However, fusion of hepatocytes stably expressing MyoD to fibro-blasts resulted in activation in the heterokaryon of muscle-specific genes of both cell types. These results imply that other regulators, present in fibroblasts but not in hepatocytes, are necessary for the activation of muscle-specific genes, and indicate that the differentiated state of a cell is dictated by its history and a dynamic interaction among the proteins that it contains.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blau, H. M., Chiu, C.-P. & Webster, C. Cell 32, 1171–1180 (1983).
Blau, H. M. et al. Science 230, 758–766 (1985).
Miller, S. C., Pavlath, G. K., Blakely, B. T. & Blau, H. M. Genes Dev. 2, 330–340 (1988).
Davis, R. L., Weintraub, H. & Lassar, A. B. Cell 51, 987–1000 (1987).
Wright, W. E., Sassoon, D. A. & Lin, V. K. Cell 56, 607–617 (1989).
Edmondson, D. G. & Olson, E. N. Genes Dev. 3, 628–640 (1989).
Murre, C., McCaw, P. S. & Baltimore, D. Cell 56, 777–783 (1989).
Darlington, G. J. Meth. Enzym. 151, 19–38 (1987).
Darlington, G. J., Kelly, J. H. & Buffone, G. J. In Vitro Cell devl Biol. 23, 349–354 (1987).
Pavlath, G. K., Rich, K., Webster, S. G. & Blau, H. M. Nature 337, 570–573 (1989).
Killary, A. M. & Fournier, R. E. K. Cell 38, 523–534 (1984).
Pavlath, G. K. & Blau, H. M. J. Cell Biol. 102, 124–130 (1986).
Weintraub, H. et al. Proc. natn. Acad. Sci. U.S.A. 86, 5434–5438 (1989).
Patek, P. Q., Collins, J. L. & Cohn, M. Nature 276, 510–511 (1978).
Lin, Z.-Y., Dechesne, C. A., Eldridge, J. & Paterson, B. M. Genes Dev. 3, 986–996 (1989).
Julius, D., Livelli, T. J. Jessell, T. M. & Axel, R. Science 244, 1057–1062 (1989).
Whitman, M. & Melton, D. A. Science 244, 803–806 (1989).
Landschulz, W. H., Johnson, P. F. & McKnight, S. L. Science 243, 1681–1688 (1989).
Braun, T., Buschhausen-Denker, G., Bober, E., Tannich, E. & Arnold, H. H. EMBO J. 8, 701–709 (1989).
Murre, C. et al. Cell 58, 537–544 (1989).
Zamoyska, R., Vollmer, A., Sizer, K., Liaw, C. & Parnes, J. Cell 43, 153–163 (1985).
Ledbetter, Z. & Herzenberg, L. Immunol. Rev. 47, 63–90 (1979).
Price, J., Turner, D. and Cepko, C. Proc. natn. Acad. Sci. U.S.A. 84, 156–160 (1987).
Walsh, F. S., Dickson, G., Moore, S. E. & Barton, C. H. Nature 339, 516 (1989).
Chiu, C.-P. & Blau, H. M. Cell 37, 879–887 (1984).
Lessard, J. L. Cell Mot. Cytoskel. 10, 349–362 (1988).
Berger, E. G. & Hesford, F. J. Proc. natn. Acad. Sci. U.S.A. 82, 4736–4739 (1985).
Silberstein, L., Webster, S. G., Travis, M. & Blau, H. M. Cell 46, 1075–1081 (1986).
Spizz, G., Roman, D., Strauss, A. & Olson, E. N. J. biol. Chem. 261, 9483–9488 (1986).
Kant, J. A., Lord, S. T. & Crabtree, G. R. Proc. natn. Acad. Sci. U.S.A. 80, 3953–3957 (1983).
Tso, J. Y., Sun X.-H., Kao, T.-H. & Wu, R. Nucleic Acid Res. 13, 2485–2502 (1985).
Gunning, P., Mohun, T., Ng, S.-Y., Ponte, P. & Kedes, L. J. molec. Evol. 20, 202–214 (1984).
Tapscott, S.J., Davis, R.L., Thayer, M. J. Cheng, P.-F., Weintraub, H. & Lassar, A. B. Science 242, 405–411 (1988).
Peterson, C. A., Gordon, H., Hall, Z. W., Paterson, B. M. & Blau, H. M. Cell (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schäfer, B., Blakely, B., Darlington, G. et al. Effect of cell history on response to helix–loop–helix family of myogenic regulators. Nature 344, 454–458 (1990). https://doi.org/10.1038/344454a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/344454a0
This article is cited by
-
Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates
Nature (2017)
-
Lineage conversion methodologies meet the reprogramming toolbox
Nature Cell Biology (2012)
-
GEP constitutes a negative feedback loop with MyoD and acts as a novel mediator in controlling skeletal muscle differentiation
Cellular and Molecular Life Sciences (2012)
-
Turning straw into gold: directing cell fate for regenerative medicine
Nature Reviews Genetics (2011)
-
Nuclear reprogramming to a pluripotent state by three approaches
Nature (2010)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.